Blue Bear Ventures Research Document
Executive Summary
Blue Bear Ventures (BBV), now evolving into Transitions First (T1ST), is a seed-stage venture capital firm focused on deep technology startups founded by scientists and engineers from top research institutions. The firm specializes in companies at the intersection of health, climate, advanced materials, and manufacturing technologies, with particular emphasis on breakthrough innovations emerging from UC Berkeley, UCSF, MIT, and Stanford.
Investment Thesis
Blue Bear Ventures engages founders working on the frontiers of science and technology with the ambition to solve the most pressing challenges we face in the world today. The firm believes that the most important aspect of deep tech companies is the founding team—they invest in co-founding teams with the right combination of technical skills and entrepreneurial spirit, not just ideas or solo founders.
The firm is transitioning into Transitions First, which broadens focus to "accelerating industrial transitions to scale" by supporting founders who are sustainably transforming manufacturing and production to meet future demands. Despite significant venture funding in climate tech, vital sectors of industry and food (responsible for 56% of greenhouse gas emissions) receive only 21% of funding—representing a $3 trillion opportunity.
Investment Focus Areas
Primary Sectors (Legacy BBV):
- Applied Biology: Gene therapy, synthetic biology, cell therapies, protein assays
- Climate & Clean Energy: Battery technology, solar, energy infrastructure, environmental monitoring
- Emerging Technology: Optical interconnects, AI/ML applications, advanced semiconductors
- Advanced Materials: Nanomaterial coatings, innovative material compositions
- Healthcare: Respiratory disease management, precision medicine, diagnostics
Expanded Focus (Transitions First):
- Net-Zero Compliant Supply Chains: Technologies enabling localized, modular industrial production
- Sustainable Petrochemical Alternatives: Bio-manufacturing and synthetic biology at scale
- Circular Economy: Novel technologies creating value from waste streams across all industrial sectors
Stage & Check Size
Stage Focus: Seed stage investments, with occasional pre-seed and Series A follow-ons
- Check Size Range: $100,000 - $400,000 (seed-stage typical range)
- Ownership Target: Typically build meaningful positions in early-stage companies
BBV focuses exclusively on early-stage companies and maintains reserves for follow-on investments in portfolio companies. They prefer to be the first institutional investor and typically lead or co-lead seed rounds.
Recent Activity & Fund Status
Recent Portfolio Developments (2024-2025):
- February 2025: Resynergi (portfolio company) secured $18M Series B extension for plastic recycling innovation
- December 2024: Ayar Labs (portfolio company) secured $155M Series D with investments from AMD, Intel Capital, NVIDIA for optical interconnects
- August 2024: Cypris Materials recognized for sustainability initiatives
- Ongoing: Active support for portfolio companies through Transitions First partnership with BCG for corporate-founder collaboration
Fund Status: Actively Deploying - Blue Bear Ventures is actively making new investments and supporting existing portfolio companies. Portfolio has generated notable wins (Ayar Labs' Series D raise, 90% survival rate across 60+ companies, $1B+ aggregate value created).
Portfolio Overview
Blue Bear Ventures has invested in 60+ startups with approximately $1B+ in cumulative value. Key portfolio companies include:
Major Portfolio Companies:
- Ayar Labs - Optical interconnects for data centers (raised $155M Series D, Dec 2024)
- Aluna - Respiratory disease management platform (raised $15.3M Series B)
- Coreshell Technologies - Nanolayer coatings for batteries
- GenEdit - Gene therapy delivery systems
- DNA Lite - Oral gene therapies
- Clarity - High-density air quality monitoring
- Aether Bio - Enzyme engineering for biological manufacturing
- BioAmp Diagnostics - Rapid antibiotic resistance diagnostics
- Correlia Biosystems - High-throughput protein assays
- ImpriMed - Precision medicine for pet cancer
- Unnatural Products - Drug discovery platform for macrocyclic peptides
- YourChoice Therapeutics - Hormone-free contraceptives
- Resynergi - Advanced plastic recycling (Transitions First, raised $18M Series B Extension, Feb 2025)
- Ruby Bio - Bio-based manufacturing (Transitions First)
- AgriLoops - Sustainable aquaponics (Transitions First, Europe)
- New Sun Road - Modular smart grid management
- EngageLively - Interactive content creation
- mFluidx - Rapid DNA testing
- Numericcal - Deep neural network optimization
- Synkrino Bio - AI-driven inflammation treatment
Portfolio Statistics:
- 60+ companies invested, advised, or launched
- $1B+ aggregate value created
- 90% survival rate across portfolio
- 2 documented exits
Team & Philosophy
Blue Bear Ventures is led by Marianne Abib-Pech and Alic Chen (Managing Partners), with Patrick Scaglia as Founding Partner/Chairman. Additional team includes Linda Maduwura (CFO), Irfan Vissandjee (Principal), and Deepak Gupta (General Partner), plus venture partners Daniel Fidler, Joanna Ridgway, and Kasra Pezeshki.
BBV places exceptional emphasis on founding teams:
- Co-founder focused: Invest in co-founding teams, not solo founders
- Technical depth: Founders are scientists and engineers from top research institutions (UC Berkeley, UCSF, MIT, Stanford, Caltech, Colorado State, Harvard, University of Minnesota)
- Mentorship approach: Partners serve as confidants and mentors, not just capital providers
- Long-term commitment: Commitment to guide companies through "entire journey," not just early stages
- Embedded support: Partners provide clarity on strategy while respecting founder autonomy
Founder Preferences
Type of Founders Backed:
- Scientists and engineers from top research institutions
- Co-founding teams (not solo founders) - critical requirement
- Technical founders with deep domain expertise
- Lab-based founders with research pedigree
- Founders committed to solving major world challenges
What They Look For:
- Breakthrough enabling technologies with clear path to cost-parity
- Non-disruptive implementation of transformative technology
- Coachable founders willing to accept mentorship
- Teams combining technical depth with entrepreneurial spirit
- Founders building companies for impact
What They Avoid:
- Solo founders without co-founding team
- Abstract ideas without technical proof points
- Disruptive technologies requiring market wholesale transformation
- Non-technical founding teams
- Pure software without deep tech component
Key Differentiators
- Deep Tech Focus: Exclusively invests in science and engineering-based companies
- Co-Founder Requirement: Unique emphasis on multi-founder teams from research labs
- Academic Network: Direct access to UC Berkeley CITRIS, top research institutions
- Long-Term Mentorship: Partners act as embedded team members, not passive investors
- Industry Expertise: Team has 30+ years in tech manufacturing, advanced materials, healthcare
- Corporate Bridge: BCG partnership creates unique access to corporate partnerships and scaling
- Global Innovation Ecosystems: T1ST expansion brings international deep tech focus
- Impact-Driven: Focus on solving major challenges (sustainability, health, climate)
Conclusion
Blue Bear Ventures is a specialized, thesis-driven seed-stage venture firm with exceptional technical depth and a unique focus on co-founder teams from top research institutions. The transition to Transitions First represents an evolution toward broader industrial transformation while maintaining core commitments to deep tech, scientist-founders, and long-term mentorship. The firm is particularly valuable for co-founding teams from research labs seeking patient capital, deep technical mentorship, and access to UC Berkeley's innovation ecosystem and BCG's corporate networks.